YY/T 1722-2020 in English
VALIDPrealbumin testing kit (immune turbidity method)
- Issued on:2020-06-30
- Implemented on:2021-12-01
- File Format:PDF
- Delivery:Via email within 1~3 business days
$175.00
本标准规定了前白蛋白测定试剂盒(免疫比浊法)的要求、试验方法、标签和使用说明书、包装、运输和贮存。本标准适用于免疫比浊法对人类血清或血浆中的前白蛋白进行定量检测的试剂盒,包括手工和半自动、全自动生化分析仪上使用的试剂。本标准不适用于干化学方法的前白蛋白测定试剂盒。
Introduction
Analysis of the core content of the standard
1. Scope of application
This standard applies to immunoturbidimetric prealbumin detection kits, including manual and automated detection systems. The key performance indicators verification must meet the following requirements:
| Verification items | Acceptance criteria | Test concentration range |
|---|---|---|
| Linear range | 30-550mg/L | Correlation coefficient≥0.990 |
| Precision | CV≤5% | 150mg/L±30mg/L |
| Accuracy | Bias±15% | Reference material verification |
2. Key Technical Requirements
2.1 Methodological Validation
The immunoturbidimetric method needs to be validated for the hook effect, and there should be no prozone phenomenon when the sample concentration is ≥1500mg/L. A typical case shows that a certain brand of reagent still maintains a linear response at a high value sample of 2000mg/L.
2.2 Performance indicators
- Detection limit : ≤15mg/L (blank mean + 2SD)
- Quantification limit : ≤30mg/L (recovery rate 80-120%)
- Linear deviation : low concentration range (30-200mg/L) ±20mg/L, high concentration range (200-550mg/L) ±10%
3. Quality control requirements
The standard references CLSI EP series documents to establish a quality control system:
| Quality control type | Frequency | Acceptance standard |
|---|---|---|
| Intra-batch precision | Each batch of reagents | CV≤5% |
| Inter-day precision | 20 consecutive days | CV≤10% |
| Calibration verification | Monthly/change batch number | Deviation≤±15% |
The implementation case in a tertiary hospital showed that when using 150mg/L and 300mg/L dual-level quality control products, the monthly CV was controlled within the range of 3.2-4.8%.
4. Implementation Suggestions
4.1 Standardized Operations
It is recommended to establish an SOP that includes the following elements:
- Sample processing specifications (centrifugation conditions, storage temperature)
- Calibrator traceability path (use of CRM standard materials)
- Interferent management (bilirubin ≤20mg/dL, hemoglobin ≤500mg/dL)
4.2 Methodological Comparison
When accepting new reagents, a comparison test of 40 clinical samples should be carried out, with the following requirements:
- Correlation coefficient r≥0.975
- Deviation in the low concentration segment ≤20mg/L
- Deviation in the high concentration segment ≤10%
5. Analysis of Standard Evolution
Main improvements compared to the 2015 version:
| Project | 2015 version | 2020 version |
|---|---|---|
| Linearity verification | 5 concentration points | 7 concentration points |
| Precision requirements | CV≤8% | CV≤5% |
| Interference test | Unspecified concentration | Specify the critical value of interferents |

Loading PDF document...
Error loading PDF. Please make sure the file is valid and try again.
We also recommend
-

YY/T 0688.2-2024 in English
Clinical laboratory testing and in vitro diagnostic systems - Performance evaluation of equipment for infectious pathogen susceptibility testing and antimicrobial susceptibility testing - Part 2: Performance evaluation of equipment for antimicrobial susce
2024-09-29 -

YY/T 0996-2015 in English
Urine formed element analyzer(digital imaging automatic identification)
2015-03-02 -

YY/T 0032-2004 in English
Haemglobin instrument
2004-11-08 -

YY/T 1155-2019 in English
Automatic luminescence immunoassay analyzer
2019-05-31 -

YY/T 1641-2018 in English
Medical biochemical incubator
2018-12-20 -

YY/T 1724-2020 in English
Free triiodothyronine (FT3)testing kit
2020-06-30